NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/29/2024
Back to search
Official data from USPTO
NASALCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
07/29/2024
Trademark type
Combined
Nice classes
5
Filing date
04/03/2016
Registration date
05/22/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2024
Last transaction
07/29/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
01/07/2007
First use in commerce
01/07/2007
Drawing code
3
Owner type
03
Owner location
Milford, DE, US
Examiner
MAZZELLA, BRANDY
Current location
Historical data usage
Mark description
The mark consists of the word "NASALCARE" where two curved lines emanate from the letter "l" representing air or vapor.
Holders and representatives
Holders
DrNaturalHealing Inc
Representatives
DrNaturalHealing Inc
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of rhinitissinusitis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticalsanti-infectives; Antibacterial pharmaceuticals; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ethers for pharmaceutical purposes; Homeopathic pharmaceuticals for use in the treatment of common coldinfluenzaallergy; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
Publications
History of USPTO decisions and trademark events.
44 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/29/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/13/2024
PUM2
OFFICE ACTION ISSUED POU2
08/29/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/29/2023
PUM1
OFFICE ACTION ISSUED POU1
08/25/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/25/2023
E815
TEAS SECTION 8 & 15 RECEIVED
08/12/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/22/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/22/2018
TMBN
TTAB RELEASE CASE TO TRADEMARKS
04/17/2018
OP.T
OPPOSITION TERMINATED NO. 999999
04/17/2018
OP.D
OPPOSITION DISMISSED NO. 999999
04/17/2018
OP.I
OPPOSITION INSTITUTED NO. 999999
11/20/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
08/19/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2017
PUBO
PUBLISHED FOR OPPOSITION
07/25/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/20/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/14/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/06/2017
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
05/23/2017
GNSF
SUBSEQUENT FINAL EMAILED
05/23/2017
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
05/23/2017
DOCK
ASSIGNED TO EXAMINER
05/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2017
ALIE
ASSIGNED TO LIE
04/28/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/10/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/23/2017
GNFR
FINAL REFUSAL E-MAILED
01/23/2017
CNFR
FINAL REFUSAL WRITTEN
01/23/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/18/2016
GNRT
NON-FINAL ACTION E-MAILED
07/18/2016
CNRT
NON-FINAL ACTION WRITTEN
07/18/2016
DOCK
ASSIGNED TO EXAMINER
07/18/2016
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/07/2016
NWAP
NEW APPLICATION ENTERED
04/06/2016
Continuous trademark protection
Get notified about every new filing that threatens NASALCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.